Carroll, P V; Christ, E R; Sönksen, P H (2000). Growth hormone replacement in adults with growth hormone deficiency: assessment of current knowledge. Trends in endocrinology and metabolism, 11(6), pp. 231-8. Kidlington, UK: Elsevier Current Trends 10.1016/S1043-2760(00)00268-X
Full text not available from this repository. (Request a copy)The recent availability of recombinant human growth hormone (GH) has led to intense investigation of the consequences of adult GH deficiency (GHD) and the effects of GH replacement. These studies have led to the identification of a characteristic syndrome of GHD consisting of decreased mood and well-being, with alterations in body composition and substrate metabolism. In both placebo-controlled and open studies, GH replacement therapy has consistently been shown to reverse or correct these features. Whether long-term GH replacement will result in a reduction of osteoporotic fractures, cardiovascular morbidity and mortality is not yet known. To date, no permanent serious adverse effects have been associated with GH replacement in GHD, and although currently expensive, it is anticipated that GH replacement will become routine in the treatment of the severely hypopituitary adult.
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Endocrinology, Diabetology and Clinical Nutrition |
UniBE Contributor: |
Christ, Emanuel |
ISSN: |
1043-2760 |
Publisher: |
Elsevier Current Trends |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 15:23 |
Last Modified: |
05 Dec 2022 14:25 |
Publisher DOI: |
10.1016/S1043-2760(00)00268-X |
PubMed ID: |
10878754 |
Web of Science ID: |
000088670500006 |
URI: |
https://boris.unibe.ch/id/eprint/37229 (FactScience: 207241) |
Actions (login required)
 |
Edit item |